| Species |
hsa |
mmu |
rno |
gga |
gga |
dre |
dme |
cel |
mcc |
cfa |
fca |
fca |
| Symbol |
AHR |
Ahr |
Ahr |
AHR1A |
AHR2 |
ahr2 |
ss |
ahr-1 |
AHR |
AHR |
LOC101101073 |
AHR |
| Function* |
aryl hydrocarbon receptor |
aryl-hydrocarbon receptor |
aryl hydrocarbon receptor |
aryl hydrocarbon receptor 1 alpha |
aryl hydrocarbon receptor 2 |
aryl hydrocarbon receptor 2 |
spineless |
Aryl hydrocarbon receptor protein 1 |
aryl hydrocarbon receptor |
aryl hydrocarbon receptor |
aryl hydrocarbon receptor-like |
aryl hydrocarbon receptor |
| Expression |
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
| Umap |
|
|
|
|
|
|
|
|
|
|
|
|
| Coexpression |
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| hsa05207 |
Chemical carcinogenesis - receptor activation |
4 |
 |
| hsa05208 |
Chemical carcinogenesis - reactive oxygen species |
4 |
 |
| hsa00140 |
Steroid hormone biosynthesis |
3 |
 |
| hsa00380 |
Tryptophan metabolism |
3 |
 |
| hsa00830 |
Retinol metabolism |
3 |
 |
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| mmu00830 |
Retinol metabolism |
6 |
|
| mmu05207 |
Chemical carcinogenesis - receptor activation |
5 |
|
| mmu00140 |
Steroid hormone biosynthesis |
4 |
|
| mmu05208 |
Chemical carcinogenesis - reactive oxygen species |
3 |
|
| mmu00980 |
Metabolism of xenobiotics by cytochrome P450 |
2 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| rno04010 |
MAPK signaling pathway |
5 |
|
| rno05200 |
Pathways in cancer |
5 |
|
| rno04014 |
Ras signaling pathway |
4 |
|
| rno04060 |
Cytokine-cytokine receptor interaction |
3 |
|
| rno04659 |
Th17 cell differentiation |
3 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| gga04141 |
Protein processing in endoplasmic reticulum |
2 |
|
| gga04350 |
TGF-beta signaling pathway |
2 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| gga00140 |
Steroid hormone biosynthesis |
3 |
|
| gga00830 |
Retinol metabolism |
3 |
|
| gga00590 |
Arachidonic acid metabolism |
2 |
|
| gga00591 |
Linoleic acid metabolism |
2 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| dre04510 |
Focal adhesion |
2 |
|
| dre04810 |
Regulation of actin cytoskeleton |
2 |
|
| dre04010 |
MAPK signaling pathway |
2 |
|
|
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| mcc05022 |
Pathways of neurodegeneration - multiple diseases |
3 |
|
| mcc05208 |
Chemical carcinogenesis - reactive oxygen species |
2 |
|
| mcc04020 |
Calcium signaling pathway |
2 |
|
| mcc05417 |
Lipid and atherosclerosis |
2 |
|
| mcc04210 |
Apoptosis |
2 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| cfa05207 |
Chemical carcinogenesis - receptor activation |
2 |
|
| cfa05208 |
Chemical carcinogenesis - reactive oxygen species |
2 |
|
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| fca04141 |
Protein processing in endoplasmic reticulum |
3 |
|
|
| GO BP* |
|
GO:0002841 [L] [N] negative regulation of T cell mediated immune response to tumor cell
|
(2 genes)
|
|
GO:1904613 [L] [N] cellular response to 2,3,7,8-tetrachlorodibenzodioxine
|
(2 genes)
|
|
GO:0030888 [L] [N] regulation of B cell proliferation
|
(4 genes)
|
|
GO:0009410 [L] [N] response to xenobiotic stimulus
|
(8 genes)
|
|
GO:0002819 [L] [N] regulation of adaptive immune response
|
(10 genes)
|
|
GO:1904322 [L] [N] cellular response to forskolin
|
(11 genes)
|
|
GO:0019933 [L] [N] cAMP-mediated signaling
|
(32 genes)
|
|
GO:0001568 [L] [N] blood vessel development
|
(40 genes)
|
|
GO:0071320 [L] [N] cellular response to cAMP
|
(54 genes)
|
|
GO:0032922 [L] [N] circadian regulation of gene expression
|
(67 genes)
|
|
GO:0030522 [L] [N] intracellular receptor signaling pathway
|
(80 genes)
|
|
GO:0009636 [L] [N] response to toxic substance
|
(81 genes)
|
|
GO:0006805 [L] [N] xenobiotic metabolic process
|
(90 genes)
|
|
GO:0010468 [L] [N] regulation of gene expression
|
(230 genes)
|
|
GO:0007049 [L] [N] cell cycle
|
(265 genes)
|
|
GO:0006355 [L] [N] regulation of transcription, DNA-templated
|
(498 genes)
|
|
GO:0045892 [L] [N] negative regulation of transcription, DNA-templated
|
(549 genes)
|
|
GO:0006915 [L] [N] apoptotic process
|
(554 genes)
|
|
GO:0045893 [L] [N] positive regulation of transcription, DNA-templated
|
(637 genes)
|
|
GO:0045944 [L] [N] positive regulation of transcription by RNA polymerase II
|
(1124 genes)
|
|
GO:0006357 [L] [N] regulation of transcription by RNA polymerase II
|
(1634 genes)
|
|
|
GO:0003243 [L] [N] circumferential growth involved in left ventricle morphogenesis
|
(1 genes)
|
|
GO:1904682 [L] [N] cellular response to 3-methylcholanthrene
|
(1 genes)
|
|
GO:1904613 [L] [N] cellular response to 2,3,7,8-tetrachlorodibenzodioxine
|
(2 genes)
|
|
GO:0002841 [L] [N] negative regulation of T cell mediated immune response to tumor cell
|
(3 genes)
|
|
GO:0040010 [L] [N] positive regulation of growth rate
|
(4 genes)
|
|
GO:1903170 [L] [N] negative regulation of calcium ion transmembrane transport
|
(4 genes)
|
|
GO:0001922 [L] [N] B-1 B cell homeostasis
|
(5 genes)
|
|
GO:0010693 [L] [N] negative regulation of alkaline phosphatase activity
|
(5 genes)
|
|
GO:0030888 [L] [N] regulation of B cell proliferation
|
(5 genes)
|
|
GO:0060420 [L] [N] regulation of heart growth
|
(5 genes)
|
|
GO:0072102 [L] [N] glomerulus morphogenesis
|
(5 genes)
|
|
GO:0035166 [L] [N] post-embryonic hemopoiesis
|
(6 genes)
|
|
GO:0060547 [L] [N] negative regulation of necrotic cell death
|
(6 genes)
|
|
GO:0060841 [L] [N] venous blood vessel development
|
(6 genes)
|
|
GO:0061009 [L] [N] common bile duct development
|
(6 genes)
|
|
GO:0030850 [L] [N] prostate gland development
|
(7 genes)
|
|
GO:0048732 [L] [N] gland development
|
(7 genes)
|
|
GO:0008015 [L] [N] blood circulation
|
(9 genes)
|
|
GO:0009410 [L] [N] response to xenobiotic stimulus
|
(10 genes)
|
|
GO:0002819 [L] [N] regulation of adaptive immune response
|
(11 genes)
|
|
GO:0033689 [L] [N] negative regulation of osteoblast proliferation
|
(11 genes)
|
|
GO:0045906 [L] [N] negative regulation of vasoconstriction
|
(11 genes)
|
|
GO:0002260 [L] [N] lymphocyte homeostasis
|
(12 genes)
|
|
GO:0045899 [L] [N] positive regulation of RNA polymerase II transcription preinitiation complex assembly
|
(12 genes)
|
|
GO:0048608 [L] [N] reproductive structure development
|
(12 genes)
|
|
GO:0003214 [L] [N] cardiac left ventricle morphogenesis
|
(13 genes)
|
|
GO:0045793 [L] [N] positive regulation of cell size
|
(13 genes)
|
|
GO:0060993 [L] [N] kidney morphogenesis
|
(14 genes)
|
|
GO:0048745 [L] [N] smooth muscle tissue development
|
(17 genes)
|
|
GO:2000279 [L] [N] negative regulation of DNA biosynthetic process
|
(17 genes)
|
|
GO:0003085 [L] [N] negative regulation of systemic arterial blood pressure
|
(22 genes)
|
|
GO:0035162 [L] [N] embryonic hemopoiesis
|
(24 genes)
|
|
GO:0097746 [L] [N] blood vessel diameter maintenance
|
(24 genes)
|
|
GO:0019933 [L] [N] cAMP-mediated signaling
|
(28 genes)
|
|
GO:0001782 [L] [N] B cell homeostasis
|
(30 genes)
|
|
GO:0043029 [L] [N] T cell homeostasis
|
(33 genes)
|
|
GO:0048514 [L] [N] blood vessel morphogenesis
|
(37 genes)
|
|
GO:0071320 [L] [N] cellular response to cAMP
|
(38 genes)
|
|
GO:0014070 [L] [N] response to organic cyclic compound
|
(40 genes)
|
|
GO:0001569 [L] [N] branching involved in blood vessel morphogenesis
|
(41 genes)
|
|
GO:0001974 [L] [N] blood vessel remodeling
|
(45 genes)
|
|
GO:0048536 [L] [N] spleen development
|
(47 genes)
|
|
GO:0001541 [L] [N] ovarian follicle development
|
(50 genes)
|
|
GO:0009636 [L] [N] response to toxic substance
|
(50 genes)
|
|
GO:0008217 [L] [N] regulation of blood pressure
|
(64 genes)
|
|
GO:1904322 [L] [N] cellular response to forskolin
|
(67 genes)
|
|
GO:0045668 [L] [N] negative regulation of osteoblast differentiation
|
(68 genes)
|
|
GO:0032922 [L] [N] circadian regulation of gene expression
|
(70 genes)
|
|
GO:0001889 [L] [N] liver development
|
(74 genes)
|
|
GO:0001568 [L] [N] blood vessel development
|
(77 genes)
|
|
GO:0043010 [L] [N] camera-type eye development
|
(80 genes)
|
|
GO:0006805 [L] [N] xenobiotic metabolic process
|
(82 genes)
|
|
GO:0030183 [L] [N] B cell differentiation
|
(85 genes)
|
|
GO:0000902 [L] [N] cell morphogenesis
|
(103 genes)
|
|
GO:0006366 [L] [N] transcription by RNA polymerase II
|
(104 genes)
|
|
GO:0048511 [L] [N] rhythmic process
|
(152 genes)
|
|
GO:0010468 [L] [N] regulation of gene expression
|
(442 genes)
|
|
GO:0002376 [L] [N] immune system process
|
(497 genes)
|
|
GO:0045892 [L] [N] negative regulation of transcription, DNA-templated
|
(561 genes)
|
|
GO:0007049 [L] [N] cell cycle
|
(625 genes)
|
|
GO:0045893 [L] [N] positive regulation of transcription, DNA-templated
|
(628 genes)
|
|
GO:0000122 [L] [N] negative regulation of transcription by RNA polymerase II
|
(931 genes)
|
|
GO:0006355 [L] [N] regulation of transcription, DNA-templated
|
(1043 genes)
|
|
GO:0045944 [L] [N] positive regulation of transcription by RNA polymerase II
|
(1172 genes)
|
|
GO:0006357 [L] [N] regulation of transcription by RNA polymerase II
|
(1494 genes)
|
|
|
GO:0003243 [L] [N] circumferential growth involved in left ventricle morphogenesis
|
(1 genes)
|
|
GO:1904682 [L] [N] cellular response to 3-methylcholanthrene
|
(1 genes)
|
|
GO:0002841 [L] [N] negative regulation of T cell mediated immune response to tumor cell
|
(2 genes)
|
|
GO:1904613 [L] [N] cellular response to 2,3,7,8-tetrachlorodibenzodioxine
|
(2 genes)
|
|
GO:0040010 [L] [N] positive regulation of growth rate
|
(4 genes)
|
|
GO:1903170 [L] [N] negative regulation of calcium ion transmembrane transport
|
(4 genes)
|
|
GO:0010693 [L] [N] negative regulation of alkaline phosphatase activity
|
(5 genes)
|
|
GO:0030888 [L] [N] regulation of B cell proliferation
|
(5 genes)
|
|
GO:0061009 [L] [N] common bile duct development
|
(5 genes)
|
|
GO:0072102 [L] [N] glomerulus morphogenesis
|
(5 genes)
|
|
GO:0035166 [L] [N] post-embryonic hemopoiesis
|
(6 genes)
|
|
GO:0060547 [L] [N] negative regulation of necrotic cell death
|
(6 genes)
|
|
GO:0060841 [L] [N] venous blood vessel development
|
(6 genes)
|
|
GO:0048732 [L] [N] gland development
|
(7 genes)
|
|
GO:0002819 [L] [N] regulation of adaptive immune response
|
(8 genes)
|
|
GO:0008015 [L] [N] blood circulation
|
(9 genes)
|
|
GO:0003214 [L] [N] cardiac left ventricle morphogenesis
|
(11 genes)
|
|
GO:0002260 [L] [N] lymphocyte homeostasis
|
(12 genes)
|
|
GO:0009410 [L] [N] response to xenobiotic stimulus
|
(12 genes)
|
|
GO:0033689 [L] [N] negative regulation of osteoblast proliferation
|
(12 genes)
|
|
GO:0045899 [L] [N] positive regulation of RNA polymerase II transcription preinitiation complex assembly
|
(12 genes)
|
|
GO:0045906 [L] [N] negative regulation of vasoconstriction
|
(12 genes)
|
|
GO:0048608 [L] [N] reproductive structure development
|
(12 genes)
|
|
GO:0060993 [L] [N] kidney morphogenesis
|
(15 genes)
|
|
GO:0045793 [L] [N] positive regulation of cell size
|
(17 genes)
|
|
GO:2000279 [L] [N] negative regulation of DNA biosynthetic process
|
(17 genes)
|
|
GO:0048745 [L] [N] smooth muscle tissue development
|
(19 genes)
|
|
GO:0097746 [L] [N] blood vessel diameter maintenance
|
(20 genes)
|
|
GO:0030850 [L] [N] prostate gland development
|
(21 genes)
|
|
GO:0003085 [L] [N] negative regulation of systemic arterial blood pressure
|
(23 genes)
|
|
GO:0035162 [L] [N] embryonic hemopoiesis
|
(24 genes)
|
|
GO:0002376 [L] [N] immune system process
|
(28 genes)
|
|
GO:0001782 [L] [N] B cell homeostasis
|
(29 genes)
|
|
GO:0019933 [L] [N] cAMP-mediated signaling
|
(31 genes)
|
|
GO:0043029 [L] [N] T cell homeostasis
|
(32 genes)
|
|
GO:0001569 [L] [N] branching involved in blood vessel morphogenesis
|
(37 genes)
|
|
GO:0048514 [L] [N] blood vessel morphogenesis
|
(37 genes)
|
|
GO:0030522 [L] [N] intracellular receptor signaling pathway
|
(39 genes)
|
|
GO:0071385 [L] [N] cellular response to glucocorticoid stimulus
|
(40 genes)
|
|
GO:0001974 [L] [N] blood vessel remodeling
|
(46 genes)
|
|
GO:0048511 [L] [N] rhythmic process
|
(47 genes)
|
|
GO:0048536 [L] [N] spleen development
|
(47 genes)
|
|
GO:1904322 [L] [N] cellular response to forskolin
|
(57 genes)
|
|
GO:0001541 [L] [N] ovarian follicle development
|
(60 genes)
|
|
GO:0045668 [L] [N] negative regulation of osteoblast differentiation
|
(62 genes)
|
|
GO:0032922 [L] [N] circadian regulation of gene expression
|
(71 genes)
|
|
GO:0006805 [L] [N] xenobiotic metabolic process
|
(72 genes)
|
|
GO:0001568 [L] [N] blood vessel development
|
(75 genes)
|
|
GO:0071320 [L] [N] cellular response to cAMP
|
(78 genes)
|
|
GO:0043010 [L] [N] camera-type eye development
|
(83 genes)
|
|
GO:0006366 [L] [N] transcription by RNA polymerase II
|
(99 genes)
|
|
GO:0000902 [L] [N] cell morphogenesis
|
(105 genes)
|
|
GO:0009636 [L] [N] response to toxic substance
|
(122 genes)
|
|
GO:0001889 [L] [N] liver development
|
(155 genes)
|
|
GO:0032355 [L] [N] response to estradiol
|
(213 genes)
|
|
GO:0051726 [L] [N] regulation of cell cycle
|
(236 genes)
|
|
GO:0014070 [L] [N] response to organic cyclic compound
|
(285 genes)
|
|
GO:0006915 [L] [N] apoptotic process
|
(370 genes)
|
|
GO:0010468 [L] [N] regulation of gene expression
|
(394 genes)
|
|
GO:0006355 [L] [N] regulation of transcription, DNA-templated
|
(515 genes)
|
|
GO:0045892 [L] [N] negative regulation of transcription, DNA-templated
|
(587 genes)
|
|
GO:0045893 [L] [N] positive regulation of transcription, DNA-templated
|
(698 genes)
|
|
GO:0000122 [L] [N] negative regulation of transcription by RNA polymerase II
|
(902 genes)
|
|
GO:0045944 [L] [N] positive regulation of transcription by RNA polymerase II
|
(1199 genes)
|
|
GO:0006357 [L] [N] regulation of transcription by RNA polymerase II
|
(1241 genes)
|
|
|
|
|
GO:0032504 [L] [N] multicellular organism reproduction
|
(1 genes)
|
|
GO:0071407 [L] [N] cellular response to organic cyclic compound
|
(7 genes)
|
|
GO:0009636 [L] [N] response to toxic substance
|
(8 genes)
|
|
GO:0001541 [L] [N] ovarian follicle development
|
(9 genes)
|
|
GO:0009410 [L] [N] response to xenobiotic stimulus
|
(15 genes)
|
|
GO:0033333 [L] [N] fin development
|
(26 genes)
|
|
GO:0071466 [L] [N] cellular response to xenobiotic stimulus
|
(31 genes)
|
|
GO:0006805 [L] [N] xenobiotic metabolic process
|
(48 genes)
|
|
GO:1904888 [L] [N] cranial skeletal system development
|
(57 genes)
|
|
GO:0045893 [L] [N] positive regulation of transcription, DNA-templated
|
(152 genes)
|
|
GO:0045944 [L] [N] positive regulation of transcription by RNA polymerase II
|
(285 genes)
|
|
GO:0006355 [L] [N] regulation of transcription, DNA-templated
|
(1084 genes)
|
|
GO:0006357 [L] [N] regulation of transcription by RNA polymerase II
|
(1403 genes)
|
|
|
GO:0010092 [L] [N] specification of animal organ identity
|
(4 genes)
|
|
GO:0045676 [L] [N] regulation of R7 cell differentiation
|
(7 genes)
|
|
GO:0006805 [L] [N] xenobiotic metabolic process
|
(9 genes)
|
|
GO:0007469 [L] [N] antennal development
|
(11 genes)
|
|
GO:0045466 [L] [N] R7 cell differentiation
|
(11 genes)
|
|
GO:0036011 [L] [N] imaginal disc-derived leg segmentation
|
(13 genes)
|
|
GO:0048800 [L] [N] antennal morphogenesis
|
(15 genes)
|
|
GO:0048814 [L] [N] regulation of dendrite morphogenesis
|
(20 genes)
|
|
GO:0007613 [L] [N] memory
|
(25 genes)
|
|
GO:0008049 [L] [N] male courtship behavior
|
(61 genes)
|
|
GO:0000122 [L] [N] negative regulation of transcription by RNA polymerase II
|
(198 genes)
|
|
GO:0006357 [L] [N] regulation of transcription by RNA polymerase II
|
(609 genes)
|
|
|
GO:0009410 [L] [N] response to xenobiotic stimulus
|
(8 genes)
|
|
GO:0040013 [L] [N] negative regulation of locomotion
|
(10 genes)
|
|
GO:0007610 [L] [N] behavior
|
(18 genes)
|
|
GO:0006805 [L] [N] xenobiotic metabolic process
|
(40 genes)
|
|
GO:0030522 [L] [N] intracellular receptor signaling pathway
|
(64 genes)
|
|
GO:0007399 [L] [N] nervous system development
|
(102 genes)
|
|
GO:0006355 [L] [N] regulation of transcription, DNA-templated
|
(541 genes)
|
|
GO:0006357 [L] [N] regulation of transcription by RNA polymerase II
|
(541 genes)
|
|
|
|
|
|
| GO CC* |
|
GO:0034752 [L] [N] cytosolic aryl hydrocarbon receptor complex
|
(1 genes)
|
|
GO:0034751 [L] [N] aryl hydrocarbon receptor complex
|
(8 genes)
|
|
GO:0005667 [L] [N] transcription regulator complex
|
(196 genes)
|
|
GO:0032991 [L] [N] protein-containing complex
|
(650 genes)
|
|
GO:0000785 [L] [N] chromatin
|
(983 genes)
|
|
GO:0005654 [L] [N] nucleoplasm
|
(3806 genes)
|
|
GO:0005737 [L] [N] cytoplasm
|
(4725 genes)
|
|
GO:0005829 [L] [N] cytosol
|
(5289 genes)
|
|
GO:0005634 [L] [N] nucleus
|
(5449 genes)
|
|
|
GO:0034752 [L] [N] cytosolic aryl hydrocarbon receptor complex
|
(1 genes)
|
|
GO:0034753 [L] [N] nuclear aryl hydrocarbon receptor complex
|
(1 genes)
|
|
GO:0034751 [L] [N] aryl hydrocarbon receptor complex
|
(8 genes)
|
|
GO:0005667 [L] [N] transcription regulator complex
|
(286 genes)
|
|
GO:0032991 [L] [N] protein-containing complex
|
(875 genes)
|
|
GO:0005829 [L] [N] cytosol
|
(3688 genes)
|
|
GO:0005634 [L] [N] nucleus
|
(6108 genes)
|
|
GO:0005737 [L] [N] cytoplasm
|
(6992 genes)
|
|
|
GO:0034751 [L] [N] aryl hydrocarbon receptor complex
|
(8 genes)
|
|
GO:0032991 [L] [N] protein-containing complex
|
(859 genes)
|
|
GO:0005829 [L] [N] cytosol
|
(3517 genes)
|
|
GO:0005634 [L] [N] nucleus
|
(4840 genes)
|
|
GO:0005737 [L] [N] cytoplasm
|
(5068 genes)
|
|
|
|
|
GO:0034751 [L] [N] aryl hydrocarbon receptor complex
|
(10 genes)
|
|
GO:0005737 [L] [N] cytoplasm
|
(3857 genes)
|
|
GO:0005634 [L] [N] nucleus
|
(4150 genes)
|
|
|
GO:0034751 [L] [N] aryl hydrocarbon receptor complex
|
(5 genes)
|
|
GO:0005829 [L] [N] cytosol
|
(1035 genes)
|
|
GO:0005634 [L] [N] nucleus
|
(2067 genes)
|
|
|
GO:0034751 [L] [N] aryl hydrocarbon receptor complex
|
(2 genes)
|
|
GO:0005634 [L] [N] nucleus
|
(2461 genes)
|
|
|
|
|
|
| GO MF* |
|
GO:0001094 [L] [N] TFIID-class transcription factor complex binding
|
(10 genes)
|
|
GO:0001223 [L] [N] transcription coactivator binding
|
(25 genes)
|
|
GO:0017025 [L] [N] TBP-class protein binding
|
(25 genes)
|
|
GO:0051879 [L] [N] Hsp90 protein binding
|
(44 genes)
|
|
GO:0070888 [L] [N] E-box binding
|
(48 genes)
|
|
GO:0000987 [L] [N] cis-regulatory region sequence-specific DNA binding
|
(52 genes)
|
|
GO:0004879 [L] [N] nuclear receptor activity
|
(52 genes)
|
|
GO:0000976 [L] [N] transcription cis-regulatory region binding
|
(212 genes)
|
|
GO:0008134 [L] [N] transcription factor binding
|
(221 genes)
|
|
GO:0046982 [L] [N] protein heterodimerization activity
|
(326 genes)
|
|
GO:0003700 [L] [N] DNA-binding transcription factor activity
|
(443 genes)
|
|
GO:1990837 [L] [N] sequence-specific double-stranded DNA binding
|
(555 genes)
|
|
GO:0042803 [L] [N] protein homodimerization activity
|
(680 genes)
|
|
GO:0003677 [L] [N] DNA binding
|
(931 genes)
|
|
GO:0000981 [L] [N] DNA-binding transcription factor activity, RNA polymerase II-specific
|
(1260 genes)
|
|
GO:0005515 [L] [N] protein binding
|
(12443 genes)
|
|
|
GO:0001094 [L] [N] TFIID-class transcription factor complex binding
|
(10 genes)
|
|
GO:0017162 [L] [N] aryl hydrocarbon receptor binding
|
(10 genes)
|
|
GO:0015643 [L] [N] toxic substance binding
|
(13 genes)
|
|
GO:0017025 [L] [N] TBP-class protein binding
|
(27 genes)
|
|
GO:0001223 [L] [N] transcription coactivator binding
|
(30 genes)
|
|
GO:0070888 [L] [N] E-box binding
|
(45 genes)
|
|
GO:0051879 [L] [N] Hsp90 protein binding
|
(50 genes)
|
|
GO:0004879 [L] [N] nuclear receptor activity
|
(53 genes)
|
|
GO:0000987 [L] [N] cis-regulatory region sequence-specific DNA binding
|
(87 genes)
|
|
GO:0051087 [L] [N] chaperone binding
|
(107 genes)
|
|
GO:0046983 [L] [N] protein dimerization activity
|
(172 genes)
|
|
GO:0000976 [L] [N] transcription cis-regulatory region binding
|
(262 genes)
|
|
GO:0046982 [L] [N] protein heterodimerization activity
|
(305 genes)
|
|
GO:0008134 [L] [N] transcription factor binding
|
(306 genes)
|
|
GO:0043565 [L] [N] sequence-specific DNA binding
|
(481 genes)
|
|
GO:1990837 [L] [N] sequence-specific double-stranded DNA binding
|
(541 genes)
|
|
GO:0003700 [L] [N] DNA-binding transcription factor activity
|
(619 genes)
|
|
GO:0042803 [L] [N] protein homodimerization activity
|
(780 genes)
|
|
GO:0000981 [L] [N] DNA-binding transcription factor activity, RNA polymerase II-specific
|
(1085 genes)
|
|
GO:0003677 [L] [N] DNA binding
|
(1729 genes)
|
|
GO:0042802 [L] [N] identical protein binding
|
(1906 genes)
|
|
GO:0005515 [L] [N] protein binding
|
(5298 genes)
|
|
|
GO:0001094 [L] [N] TFIID-class transcription factor complex binding
|
(10 genes)
|
|
GO:0017162 [L] [N] aryl hydrocarbon receptor binding
|
(10 genes)
|
|
GO:0015643 [L] [N] toxic substance binding
|
(13 genes)
|
|
GO:0017025 [L] [N] TBP-class protein binding
|
(27 genes)
|
|
GO:0001223 [L] [N] transcription coactivator binding
|
(31 genes)
|
|
GO:0070888 [L] [N] E-box binding
|
(45 genes)
|
|
GO:0051879 [L] [N] Hsp90 protein binding
|
(50 genes)
|
|
GO:0004879 [L] [N] nuclear receptor activity
|
(52 genes)
|
|
GO:0000987 [L] [N] cis-regulatory region sequence-specific DNA binding
|
(87 genes)
|
|
GO:0051087 [L] [N] chaperone binding
|
(103 genes)
|
|
GO:0046983 [L] [N] protein dimerization activity
|
(144 genes)
|
|
GO:0000976 [L] [N] transcription cis-regulatory region binding
|
(251 genes)
|
|
GO:0046982 [L] [N] protein heterodimerization activity
|
(329 genes)
|
|
GO:0043565 [L] [N] sequence-specific DNA binding
|
(427 genes)
|
|
GO:0003700 [L] [N] DNA-binding transcription factor activity
|
(435 genes)
|
|
GO:1990837 [L] [N] sequence-specific double-stranded DNA binding
|
(532 genes)
|
|
GO:0042803 [L] [N] protein homodimerization activity
|
(699 genes)
|
|
GO:0000981 [L] [N] DNA-binding transcription factor activity, RNA polymerase II-specific
|
(846 genes)
|
|
GO:0003677 [L] [N] DNA binding
|
(908 genes)
|
|
GO:0005515 [L] [N] protein binding
|
(1723 genes)
|
|
GO:0042802 [L] [N] identical protein binding
|
(1829 genes)
|
|
|
|
|
GO:0098531 [L] [N] ligand-activated transcription factor activity
|
(3 genes)
|
|
GO:0004879 [L] [N] nuclear receptor activity
|
(71 genes)
|
|
GO:0000976 [L] [N] transcription cis-regulatory region binding
|
(76 genes)
|
|
GO:0046983 [L] [N] protein dimerization activity
|
(191 genes)
|
|
GO:0043565 [L] [N] sequence-specific DNA binding
|
(281 genes)
|
|
GO:0000981 [L] [N] DNA-binding transcription factor activity, RNA polymerase II-specific
|
(1110 genes)
|
|
GO:0003677 [L] [N] DNA binding
|
(1414 genes)
|
|
|
GO:0004879 [L] [N] nuclear receptor activity
|
(24 genes)
|
|
GO:0000976 [L] [N] transcription cis-regulatory region binding
|
(99 genes)
|
|
GO:0046982 [L] [N] protein heterodimerization activity
|
(211 genes)
|
|
GO:0000981 [L] [N] DNA-binding transcription factor activity, RNA polymerase II-specific
|
(417 genes)
|
|
|
GO:0000976 [L] [N] transcription cis-regulatory region binding
|
(11 genes)
|
|
GO:0061629 [L] [N] RNA polymerase II-specific DNA-binding transcription factor binding
|
(26 genes)
|
|
GO:0046983 [L] [N] protein dimerization activity
|
(61 genes)
|
|
GO:0004879 [L] [N] nuclear receptor activity
|
(65 genes)
|
|
GO:0003677 [L] [N] DNA binding
|
(846 genes)
|
|
GO:0005515 [L] [N] protein binding
|
(1120 genes)
|
|
|
|
|
|
| KEGG* |
| 04659 |
Th17 cell differentiation |
 |
| 04934 |
Cushing syndrome |
|
| 05207 |
Chemical carcinogenesis - receptor activation |
|
| 05208 |
Chemical carcinogenesis - reactive oxygen species |
|
|
| 04659 |
Th17 cell differentiation |
|
| 04934 |
Cushing syndrome |
|
| 05207 |
Chemical carcinogenesis - receptor activation |
|
| 05208 |
Chemical carcinogenesis - reactive oxygen species |
|
|
| 04659 |
Th17 cell differentiation |
|
| 04934 |
Cushing syndrome |
|
| 05207 |
Chemical carcinogenesis - receptor activation |
|
| 05208 |
Chemical carcinogenesis - reactive oxygen species |
|
|
|
|
|
|
|
| 04659 |
Th17 cell differentiation |
|
| 04934 |
Cushing syndrome |
|
| 05207 |
Chemical carcinogenesis - receptor activation |
|
| 05208 |
Chemical carcinogenesis - reactive oxygen species |
|
|
| 04659 |
Th17 cell differentiation |
|
| 04934 |
Cushing syndrome |
|
| 05207 |
Chemical carcinogenesis - receptor activation |
|
| 05208 |
Chemical carcinogenesis - reactive oxygen species |
|
|
| 04659 |
Th17 cell differentiation |
|
| 04934 |
Cushing syndrome |
|
| 05207 |
Chemical carcinogenesis - receptor activation |
|
| 05208 |
Chemical carcinogenesis - reactive oxygen species |
|
|
| 04659 |
Th17 cell differentiation |
|
| 04934 |
Cushing syndrome |
|
| 05207 |
Chemical carcinogenesis - receptor activation |
|
| 05208 |
Chemical carcinogenesis - reactive oxygen species |
|
|
| Entrez Gene ID* |
196 |
11622 |
25690 |
373907 |
424033 |
30517 |
41988 |
172788 |
714254 |
475251 |
101101073 |
101084947 |
